Chinese woman with ALS hosts farewell ceremony at funeral home, says disease cannot freeze ‘optimism, love and hope’

A Chinese woman living with ALS held a farewell ceremony at a funeral home to celebrate love, gratitude and life.
ALS News Today

SOD1-ALS therapy Qalsody moves closer to public funding in Canada

Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...
ALS News Today

FDA clears pivotal Phase 3 trial of new ALS oral therapy pridopidine

The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...
Health Digest on MSN

Eric Dane's Brutal ALS Battle Has Given Him New Purpose Despite 'No Reason' To Be Positive

In 2025, Hollywood star Eric Dane shared with the world that he had been diagnosed with a serious disorder that has left him ...

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...
Cantech Letter

Canadian HTA Assessments Recognize Therapeutic Value of QALSODY™ (tofersen injection) and its Potential to Modify Disease Progression in Individuals Living with S…

Biogen Canada Inc. is encouraged by the recent Health Technology Assessment (HTA) evaluations issued by Canada’s Drug Agency ...

22 investigates: Man living with ALS uses voice to raise awareness before his last breath

A local man is using what time he has left to to raise awareness about the financial and emotional toll A-L-S, also known as ...

Prilenia and Ferrer Announce FDA Clearance to Start the "PREVAiLS" Pivotal Phase 3 Study with Pridopidine in ALS

In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...

FDA Approves Amgen's UPLIZNA(R) (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen's UPLIZNA(R) (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...

Merry Christmas Neurizon as FDA clears NUZ-001 for HEALEY ALS Platform Trial

The US Food and Drug Administration (FDA) has granted Neurizon Therapeutics an early Christmas present by completing its ...

FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen’s UPLIZNA ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...